Raymond James & Associates’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$19.7M Buy
663,302
+12,418
+2% +$386K 0.01% 826
2024
Q2
$21.9M Buy
650,884
+77,816
+14% +$2.69M 0.01% 732
2024
Q1
$20.7M Buy
573,068
+9,550
+2% +$330K 0.01% 763
2023
Q4
$18.4M Buy
563,518
+2,234
+0.4% +$69K 0.01% 780
2023
Q3
$18.3M Buy
561,284
+14,596
+3% +$468K 0.02% 722
2023
Q2
$16M Buy
546,688
+213,785
+64% +$5.89M 0.01% 811
2023
Q1
$9.33M Buy
332,903
+49,470
+17% +$1.39M 0.01% 1067
2022
Q4
$7.73M Sell
283,433
-3,795
-1% -$101K 0.01% 1152
2022
Q3
$6.85M Buy
287,228
+15,625
+6% +$429K 0.01% 1170
2022
Q2
$7.6M Buy
271,603
+24,406
+10% +$710K 0.01% 1137
2022
Q1
$7.21M Sell
247,197
-37,895
-13% -$1.18M 0.01% 1253
2021
Q4
$9.94M Buy
285,092
+38,253
+15% +$1.36M 0.01% 1112
2021
Q3
$8.14M Sell
246,839
-11,205
-4% -$362K 0.01% 1179
2021
Q2
$8.54M Buy
258,044
+14,763
+6% +$512K 0.01% 1162
2021
Q1
$8.68M Sell
243,281
-4,061
-2% -$144K 0.01% 1108
2020
Q4
$8.39M Buy
247,342
+2,602
+1% +$80.2K 0.01% 1051
2020
Q3
$6.3M Sell
244,740
-27,108
-10% -$720K 0.01% 1102
2020
Q2
$7.01M Sell
271,848
-23,651
-8% -$593K 0.01% 1005
2020
Q1
$6.55M Buy
295,499
+75,093
+34% +$2.09M 0.01% 922
2019
Q4
$6.39M Buy
220,406
+1,208
+0.6% +$34K 0.01% 1114
2019
Q3
$6.04M Sell
219,198
-42,889
-16% -$1.13M 0.01% 1119
2019
Q2
$6.45M Sell
262,087
-15,051
-5% -$341K 0.01% 1087
2019
Q1
$5.73M Buy
277,138
+92,042
+50% +$1.92M 0.01% 1113
2018
Q4
$3.74M Sell
185,096
-14,015
-7% -$294K 0.01% 1243
2018
Q3
$4.27M Buy
199,111
+20,376
+11% +$471K 0.01% 1312
2018
Q2
$4.11M Buy
178,735
+51,673
+41% +$1.23M 0.01% 1317
2018
Q1
$2.92M Sell
127,062
-577
-0.5% -$13.1K 0.01% 1458
2017
Q4
$2.67M Buy
127,639
+7,982
+7% +$159K ﹤0.01% 1501
2017
Q3
$2.37M Buy
119,657
+68,041
+132% +$1.24M ﹤0.01% 1533
2017
Q2
$979K Sell
51,616
-81,989
-61% -$1.6M ﹤0.01% 2038
2017
Q1
$2.85M Sell
133,605
-8,728
-6% -$183K 0.01% 1330
2016
Q4
$2.8M Sell
142,333
-2,640
-2% -$48.1K 0.01% 1286
2016
Q3
$2.55M Buy
144,973
+87,480
+152% +$1.51M 0.01% 1313
2016
Q2
$888K Buy
57,493
+10,726
+23% +$170K ﹤0.01% 1800
2016
Q1
$734K Sell
46,767
-12,358
-21% -$180K ﹤0.01% 1834
2015
Q4
$947K Sell
59,125
-2,206
-4% -$35.6K ﹤0.01% 1662
2015
Q3
$951K Buy
61,331
+6,263
+11% +$99.5K ﹤0.01% 1620
2015
Q2
$904K Sell
55,068
-86,694
-61% -$1.52M ﹤0.01% 1788
2015
Q1
$2.59M Sell
141,762
-12,596
-8% -$222K 0.01% 1094
2014
Q4
$2.79M Buy
+154,358
New +$2.56M 0.01% 981
2013
Q3
Sell
-45,454
Closed -$524K 1930
2013
Q2
$524K Buy
+45,454
New +$512K ﹤0.01% 1501

Other funds holding GNTX

Raymond James & Associates's GNTX Position: Q3 2024 in Review

Raymond James & Associates increased its Gentex (GNTX) stake by 1.9% in Q3 2024, buying an estimated $386K and bringing the position to 663,302 shares worth $19.7M. The position accounts for 0.01% of the portfolio, ranked #826.

Raymond James & Associates first reported a position in GNTX in Q2 2013 and has held it in 41 quarters since. The position peaked at $21.9M in Q2 2024. 525 funds tracked by Wall St. Rank hold GNTX as of Q3 2024.

  • Raymond James & Associates held 663,302 shares of Gentex worth $19.7M as of Q3 2024.
  • Raymond James & Associates bought 12,418 Gentex shares in Q3 2024, an estimated $386K.
  • Gentex made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #826 holding.
  • Raymond James & Associates first reported a position in Gentex in Q2 2013 and has held it in 41 quarters since.
  • Raymond James & Associates's Gentex position peaked at $21.9M in Q2 2024.
  • 525 funds tracked by Wall St. Rank held Gentex as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.